The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia.
about
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brainMammalian nicotinic acetylcholine receptors: from structure to functionThe glial growth factors deficiency and synaptic destabilization hypothesis of schizophreniaα7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimumInside-out neuropharmacology of nicotinic drugsA genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug targetVarenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceTargeting Functional Biomarkers in Schizophrenia with Neuroimaging.Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.Evidence for gamma and beta sensory gating deficits as translational endophenotypes for schizophrenia.Distinct neural generators of sensory gating in schizophrenia.TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.Neuroimaging biomarkers for early drug development in schizophreniaNeuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine ReceptorMultimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophreniaCortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.α7-Nicotinic acetylcholine receptor: role in early odor learning preference in miceThe duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7.α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-conceptCould vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia?Early biomarkers of psychosisDiminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use.GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid.An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification.Long-lasting changes in neural networks to compensate for altered nicotinic input.Towards a muscarinic hypothesis of schizophrenia.Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophreniaNicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch.A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.
P2860
Q24564986-07FCBF1B-1DDD-46C0-8AEE-2C0A03A520F5Q24647069-0C504695-572A-493D-9A8F-DCC2B128609EQ24798030-51FFD7E1-6000-43A6-BA18-5B2CFDCF2C48Q26852967-C997FBB7-BEDD-4120-9347-B232C4CC54A9Q27010347-1246A8D3-D18B-4C1C-849D-B757B046731EQ28487183-A9C28F35-4A5F-4166-980C-6FEEF3371561Q28552053-26D2A1B7-78CE-49E9-A3DA-456392ED1DC9Q29618819-8D10B688-4501-43C4-8ABF-A00B420FA844Q30366697-ABE98C2D-87BA-4DF9-AFB2-E0541F1ACB59Q30381001-F06A560C-DAFD-436A-B01B-3300FE3F01D5Q30424468-CE7AF53E-E993-4A20-BF5C-752B688399C7Q30469162-08B72BBB-8014-498E-90F3-44A3EE7AC8E8Q30478035-619B79E7-160D-4BE0-B69E-8F4D9D133CFDQ33632516-9C9BD891-996E-4C80-90C3-27883E562201Q33740560-01CF8E0B-51F6-47D4-BA32-85B1DA8B2E65Q33907356-458707E7-CA1E-4C51-8241-B4C62F9F7001Q34060159-C29947E8-BCE9-428F-B174-7F06204C6A5CQ34238932-C99EEA68-3E31-4FD4-9AA2-B4B9930CE18EQ34249085-B2F200D6-4AF1-421A-BE16-F1C7E424DE3BQ34501147-A548243B-E0B1-417F-A983-53343B2DB05CQ34561031-C5778939-4F1D-4F8B-9DA0-6FB050817935Q34571365-A779F954-4EC6-49FF-A89C-9C696027533EQ34653803-5077EE6E-CA96-42B9-8491-402ADFFAD34BQ34952107-2776094D-7CB5-4E78-A14B-5AC2CCDC5304Q35129327-114D9042-CFBA-47C6-BA9F-E980DC132DC0Q35155905-7652E7A9-E335-4A77-B5C4-68E4D324F98BQ35211484-AD2A394D-FC6A-4EE9-85DC-5C01729C21B1Q35236579-1EBF7C03-A593-4697-9AE3-FC14C428AE1EQ35390572-1296B15E-3DE1-4ADD-B8AF-C2F72D88043EQ35469889-E7A1258A-26D0-4B63-8BB9-B4343A3C77EEQ35837691-87CEC550-84BD-40D9-AFFA-EFAA01B229BBQ35913188-AA1CEDE6-3E5F-4F0C-BFA4-D17DAD3FF174Q35990855-06AE9A6D-178D-4F5C-BFC4-3F48510FA049Q36144802-FCAEDFCE-7DFB-40C3-9739-0E2BD7D66F29Q36673957-21B8C0D4-580C-4162-9F71-0C934AF696EDQ36848924-770C0390-D138-4C50-A587-FC2F71610A5CQ36917265-D9265123-B050-493C-852D-487D4918F9B8Q37349098-EE9C409D-6284-4096-8576-70F25E8F18CEQ37962995-0FDB1279-B165-470A-AECD-212BDBA47DCBQ38064198-83F1DE8D-F2A2-4A63-BB40-6393A7610045
P2860
The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@ast
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@en
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@nl
type
label
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@ast
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@en
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@nl
prefLabel
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@ast
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@en
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@nl
P2093
P1476
The alpha7-nicotinic acetylcho ...... interneurons in schizophrenia.
@en
P2093
P304
P356
10.1016/S0891-0618(00)00109-5
P577
2000-12-01T00:00:00Z